Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quality Assurance Project in Patients With Advanced Prostate Carcinoma - Evaluation of Tolerability, Quality of Life and Usage of Zoladex 10,8 SafeSystem

NCT00540059 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00540059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00540059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quality Assurance Project in Patients With Advanced Prostate Carcinoma - Evaluation of Tolerability, Quality of Life and Usage of Zoladex 10,8 SafeSystem
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
June 30, 2005
Completion date
Not reported
Enrollment
1,950 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prostate carcinoma